Long-Term Outcomes of LAA Contrast Flow in CT Scans After Endocardial LAA Closure: The CF-CT Registry
Part of paid clinical trials in Overland Park, Kansas.
- Sponsor
- Kansas City Heart Rhythm Research Foundation
- Study ID
- NCT06075628
- Status
- Recruiting
Conditions
- Atrial Fibrillation
- Ischemic Stroke, Acute
Eligibility Criteria
- Sex
- ALL
- Age
- 18 Years - N/A
- Healthy Volunteers
- Not accepted
Interventions
- Left Atrial Appendage Occlusion — OTHERAcute ischemic stroke is a major cause of morbidity and mortality in non-valvular Atrial Fibrillation (AF). Oral Anticoagulation (OAC) with Warfarin and Direct oral anticoagulants (DOACs) has been the mainstay to prevent systemic thromboembolism (STE) in this patient population. It is estimated that around 50% of patients who have AF with indication for OAC end up being not on OAC due to bleeding complications leaving them at high risk for developing STE. Left atrial appendage occlusion (LAAO) offers an option in such population.
Study Details
This study is intended to assess the incidence and correlation to the development of peri-device leaks (PDLs), device related thrombosis (DRTs) and cerebral vascular accident (CVA)/transient ischemic attacks (TIAs) in association with left atrial appendage contrast flow (LAA-CF). It will be a multi-center, retrospective study. Approximately 100 subject charts will be reviewed.
Key Dates
- Start date
- Jul 24, 2023
- Status verified
- Aug 2025
- Primary completion
- Dec 31, 2025
- Completion
- Dec 31, 2025
Study Design
- Enrollment
- 100 participants (estimated)
Arms
- Arm: Amplatzer AmuletThis is the group of subjects who are implanted with Amplatzer Amulet device.
- Arm: Watchman / Watchman FLXThis is the group of subjects who are implanted with Watchman / Watchman FLX device.
Primary Outcome Measure
Incidence and correlation to the development of Peri-Device Leak (PDLs), Device-Related Thrombus (DRT) or cerebral vascular accident (CVA) in association with LAA-CF [ Time Frame: 12 Months ]
Central Contacts
- Donita Atkins816-651-1969
Locations (1)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| Kansas City Heart Rhythm Institute | Overland Park | Kansas | 66211 | Dhanunjaya Lakkireddy, MD (PRINCIPAL_INVESTIGATOR) |
Find similar trials in Overland Park, KS
By condition
By specialty
By research site
Related Studies
- Anticoagulation in ICH Survivors for Stroke Prevention and RecoveryPHASE3 · Recruiting · Yale University · Birmingham, Alabama
- Tracking Results of Ablations to Combat AF Registry Generation 2Recruiting · AtriCure, Inc. · Huntsville, Alabama
- The CONFORM Pivotal TrialRecruiting · Conformal Medical, Inc · Birmingham, Alabama
- Impact of Steerable Delivery Sheaths on Successful Closure of LA A With AMULETNot Yet Recruiting · Kansas City Heart Rhythm Research Foundation · Overland Park, Kansas